Fulgent Genetics, Inc. (FLGT) Advances Cancer TherapiesFulgent Genetics, Inc.BATS:FLGTtraderspro_chartsFulgent Genetics, Inc. (FLGT) provides genetic and diagnostic testing, pathology services, and precision oncology tools while also developing cancer therapies. Its testing covers hereditary cancer, rare diseases, reproductive health, and oncology. Growth comes from expanding laboratory volumes, broader oncology testing, AI-driven lab efficiency, partnerships, and progress in its FID-007 and FID-022 cancer drug pipeline. Fulgent Genetics On the chart, FLGT printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.